title: Cancer in cardiovascular drug trials and vice versa: a personal perspective.
authors.affiliation: Harvard Medical School, Cardiovascular Division, Brigham and Women's Hospital, 75 Francis Street, Boston, MA 02115, USA. mpfeffer@rics.bwh.harvard.edu
authors.forename: Marc A
authors.initials: MA
authors.lastname: Pfeffer
mesh_terms: D057911:Angiotensin Receptor Antagonists / Q000009:adverse effects*; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000009:adverse effects*; D000970:Antineoplastic Agents / Q000009:adverse effects; D002317:Cardiovascular Agents / Q000009:adverse effects*; D002318:Cardiovascular Diseases / Q000139:chemically induced / Q000188:drug therapy*; D006801:Humans; D009369:Neoplasms / Q000139:chemically induced* / Q000517:prevention & control; D016032:Randomized Controlled Trials as Topic
chemical_list: D057911:Angiotensin Receptor Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors; D000970:Antineoplastic Agents; D002317:Cardiovascular Agents